Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7896537rdf:typepubmed:Citationlld:pubmed
pubmed-article:7896537lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:7896537lifeskim:mentionsumls-concept:C0016057lld:lifeskim
pubmed-article:7896537lifeskim:mentionsumls-concept:C0242640lld:lifeskim
pubmed-article:7896537lifeskim:mentionsumls-concept:C0016367lld:lifeskim
pubmed-article:7896537lifeskim:mentionsumls-concept:C0039961lld:lifeskim
pubmed-article:7896537lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:7896537pubmed:issue3lld:pubmed
pubmed-article:7896537pubmed:dateCreated1995-4-26lld:pubmed
pubmed-article:7896537pubmed:abstractTextThe purpose of this study was to identify calcium channel and calmodulin antagonists effective in increasing the cytotoxic effects of several chemotherapeutic drugs against UV-2237 murine fibrosarcoma MDR cells. Among 8 compounds tested at nontoxic concentrations, flupentixol, a piperazine-substituted thioxanthene, was the most potent in enhancing the cytotoxicity of anticancer drugs commonly associated with the multidrug resistant (MDR) phenotype, such as Adriamycin, actinomycin D, vinblastine, and vincristine, but not 5-fluorouracil, a drug usually unaffected by MDR. The chemosensitizing effects of flupentixol were produced by increasing intracellular drug accumulation via a mechanism unrelated to the binding of the plasma membrane P-glycoprotein.lld:pubmed
pubmed-article:7896537pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896537pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896537pubmed:languageenglld:pubmed
pubmed-article:7896537pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896537pubmed:citationSubsetIMlld:pubmed
pubmed-article:7896537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896537pubmed:statusMEDLINElld:pubmed
pubmed-article:7896537pubmed:issn0167-6997lld:pubmed
pubmed-article:7896537pubmed:authorpubmed-author:PosteGGlld:pubmed
pubmed-article:7896537pubmed:authorpubmed-author:FidlerI JIJlld:pubmed
pubmed-article:7896537pubmed:authorpubmed-author:FauMMlld:pubmed
pubmed-article:7896537pubmed:authorpubmed-author:BullTTlld:pubmed
pubmed-article:7896537pubmed:authorpubmed-author:SeibEElld:pubmed
pubmed-article:7896537pubmed:authorpubmed-author:EarnestL ELElld:pubmed
pubmed-article:7896537pubmed:authorpubmed-author:ClyneR KRKlld:pubmed
pubmed-article:7896537pubmed:issnTypePrintlld:pubmed
pubmed-article:7896537pubmed:volume12lld:pubmed
pubmed-article:7896537pubmed:ownerNLMlld:pubmed
pubmed-article:7896537pubmed:authorsCompleteYlld:pubmed
pubmed-article:7896537pubmed:pagination185-95lld:pubmed
pubmed-article:7896537pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:meshHeadingpubmed-meshheading:7896537-...lld:pubmed
pubmed-article:7896537pubmed:year1994lld:pubmed
pubmed-article:7896537pubmed:articleTitleReversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol.lld:pubmed
pubmed-article:7896537pubmed:affiliationDepartment of Cell Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.lld:pubmed
pubmed-article:7896537pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7896537pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7896537pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7896537lld:pubmed